By Michele Maatouk
Date: Tuesday 06 Jan 2026
(Sharecast News) - US biotech firm Amgen said on Tuesday that it has bought Dark Blue Therapeutics, a UK biotechnology company specialising in cancer treatments, for up to $840m.
| SEP cashes in as US giant Amgen buys cancer drug... | 26-Jan-2011 | The Scotsman |
| Amgen Buys a Cancer Drug Maker | 25-Jan-2011 | New York Times |
| Tech Ticker | 16-Dec-2010 | BayArea.com |
| Amgen drug delayed spread of prostate cancer to ... | 15-Dec-2010 | LA Times |
| Business Briefing | 24-Dec-2009 | LA Times |
| Currency | US Dollars |
| Share Price | $ 421.51 |
| Change Today | $ -2.13 |
| % Change | -0.50 % |
| 52 Week High | $444.91 |
| 52 Week Low | $282.20 |
| Volume | 3,130,965 |
| Shares Issued | 538.80m |
| Market Cap | $227,110m |
| Beta | 0.02 |
| RiskGrade | 100 |
| Time | Volume / Share Price |
| 16:00 | 40 @ $421.67 |
| 15:59 | 60 @ $421.50 |
| 15:59 | 100 @ $421.50 |
| 15:59 | 40 @ $421.50 |
| 15:59 | 47 @ $421.51 |
You are here: research